107 related articles for article (PubMed ID: 1905991)
1. Cryoprecipitate for uremic bleeding.
Davenport R
Clin Pharm; 1991 Jun; 10(6):429. PubMed ID: 1905991
[No Abstract] [Full Text] [Related]
2. Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
Triulzi DJ; Blumberg N
Yale J Biol Med; 1990; 63(1):1-7. PubMed ID: 2113328
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic manipulations in uremic bleeding.
Watson AJ; Whelton A
J Clin Pharmacol; 1985; 25(5):315-7. PubMed ID: 3928704
[No Abstract] [Full Text] [Related]
4. Evidence-based treatment recommendations for uremic bleeding.
Hedges SJ; Dehoney SB; Hooper JS; Amanzadeh J; Busti AJ
Nat Clin Pract Nephrol; 2007 Mar; 3(3):138-53. PubMed ID: 17322926
[TBL] [Abstract][Full Text] [Related]
5. Management of uremic bleeding.
Couch P; Stumpf JL
Clin Pharm; 1990 Sep; 9(9):673-81. PubMed ID: 2171866
[TBL] [Abstract][Full Text] [Related]
6. Bleeding in uremia--a clinical challenge.
Carvalho AC
N Engl J Med; 1983 Jan; 308(1):38-9. PubMed ID: 6401191
[No Abstract] [Full Text] [Related]
7. Bleeding disorders in uremia: pathophysiology and treatment.
Remuzzi G
Adv Nephrol Necker Hosp; 1989; 18():171-86. PubMed ID: 2493714
[TBL] [Abstract][Full Text] [Related]
8. Cryoprecipitate revisited.
Aledort LM
Transfusion; 1988; 28(4):295-6. PubMed ID: 3133841
[No Abstract] [Full Text] [Related]
9. Cryoprecipitate: uses and alternatives.
Poon MC
Transfus Med Rev; 1993 Jul; 7(3):180-92. PubMed ID: 8347984
[No Abstract] [Full Text] [Related]
10. Desmopressin: a new drug for the treatment of bleeding disorders.
Haas D; Nace GS
J Nephrol Nurs; 1985; 2(2):72-3. PubMed ID: 3845983
[No Abstract] [Full Text] [Related]
11. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
[No Abstract] [Full Text] [Related]
12. Cryoprecipitate. Patterns of use.
Pantanowitz L; Kruskall MS; Uhl L
Am J Clin Pathol; 2003 Jun; 119(6):874-81. PubMed ID: 12817436
[TBL] [Abstract][Full Text] [Related]
13. The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate.
Quitt M; Froom P; Veisler A; Falber V; Sova J; Aghai E
Arch Intern Med; 1990 Aug; 150(8):1744-6. PubMed ID: 2116786
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
Alarcón F; Mezzano D; Vial S; Pereira J
Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
[No Abstract] [Full Text] [Related]
15. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
Rydzewski A; Rowiński M; Myśliwiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
[TBL] [Abstract][Full Text] [Related]
16. DDAVP, cryoprecipitate, and highly 'purified' factor VIII concentrate in uremia.
Juhl A
Nephron; 1986; 43(4):305-6. PubMed ID: 3090461
[No Abstract] [Full Text] [Related]
17. Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
Shapiro MD; Kelleher SP
Am J Nephrol; 1984; 4(4):260-1. PubMed ID: 6332534
[TBL] [Abstract][Full Text] [Related]
18. DDAVP and life-threatening diffuse gastric bleeding in uraemia. Case report.
Juhl A; Jørgensen F
Acta Chir Scand; 1987 Jan; 153(1):75-7. PubMed ID: 3495087
[TBL] [Abstract][Full Text] [Related]
19. Bleeding in renal failure.
Remuzzi G
Lancet; 1988 May; 1(8596):1205-8. PubMed ID: 2897015
[No Abstract] [Full Text] [Related]
20. A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
Foster PA
Thromb Haemost; 1995 Nov; 74(5):1370-8. PubMed ID: 8607125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
